Dopaminergic pathway reconstruction by Akt/Rheb-induced axon regeneration

Annals of Neurology

Volumn 70, Issue 1, 2011, Pages 110-120

  Kim, Sang Ryong ^a   Chen, Xiqun ^a   Oo, Tinmarla F ^a   Kareva, Tatyana ^a   Yarygina, Olga ^a   Wang, Chuansong ^b   During, Matthew ^b   Kholodilov, Nikolai ^a   Burke, Robert E ^a  

^a Columbia University ^*  (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; NEUROTOXIN; OXIDOPAMINE; PROTEIN KINASE B; RHEB PROTEIN;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CELL STRUCTURE; CONTROLLED STUDY; CONVALESCENCE; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; HISTOLOGY; MALE; MOUSE; MYRISTYLATION; NERVE FIBER; NERVE FIBER REGENERATION; NERVE FUNCTION; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; REINNERVATION; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

ANIMALS; AXONS; DEPENDOVIRUS; DOPAMINE; GENETIC VECTORS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MONOMERIC GTP-BINDING PROTEINS; NERVE REGENERATION; NEURONS; NEUROPEPTIDES; PARKINSON DISEASE; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

EID: 79960806650     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22383     Document Type: Article

References (36)

1. Filbin MT,. Recapitulate development to promote axonal regeneration: good or bad approach? Philos Trans R Soc Lond B Biol Sci 2006; 361: 1565-1574. (Pubitemid 44450211)
2. Benowitz LI, Yin Y,. Combinatorial treatments for promoting axon regeneration in the CNS: strategies for overcoming inhibitory signals and activating neurons' intrinsic growth state. Dev Neurobiol 2007; 67: 1148-1165. (Pubitemid 47229865)
3. Nash M, Pribiag H, Fournier AE, et al. Central nervous system regeneration inhibitors and their intracellular substrates. Mol Neurobiol 2009; 40: 224-235.
4. Sun F, He Z,. Neuronal intrinsic barriers for axon regeneration in the adult CNS. Curr Opin Neurobiol 2010; 20: 510-518.
5. Yang Y, Kim AH, Bonni A,. The dynamic ubiquitin ligase duo: Cdh1-APC and Cdc20-APC regulate neuronal morphogenesis and connectivity. Curr Opin Neurobiol 2010; 20: 92-99.
6. Park KK, Liu K, Hu Y, et al. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 2008; 322: 963-966.
7. Thompson LH, Grealish S, Kirik D, et al. Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain. Eur J Neurosci 2009; 30: 625-638.
8. Sauer H, Oertel WH,. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6 hydroxydopamine a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 1994; 59: 401-415. (Pubitemid 24098798)
9. Ries V, Silva RM, Oo TF, et al. JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration. J Neurochem 2008; 107: 1578-1588.
10. Hedreen JC, Chalmers JP,. Neuronal degeneration in rat brain induced by 6-hydroxydopamine; a histological and biochemical study. Brain Res 1972; 47: 1-36.
11. Sawamoto K, Nakao N, Kobayashi K, et al. Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons. Proc Natl Acad Sci U S A 2001; 98: 6423-6428. (Pubitemid 32488253)
12. Wullschleger S, Loewith R, Hall MN,. TOR signaling in growth and metabolism. Cell 2006; 124: 471-484. (Pubitemid 43199434)
13. Pellman D, Garber EA, Cross FR, et al. An N-terminal peptide from p60src can direct myristoylation and plasma membrane localization when fused to heterologous proteins. Nature 1985; 314: 374-377. (Pubitemid 15122121)
14. Ahmed NN, Grimes HL, Bellacosa A, et al. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci U S A 1997; 94: 3627-3632. (Pubitemid 27180423)
15. Yan L, Findlay GM, Jones R, et al. Hyperactivation of mammalian target of rapamycin (mTOR) signaling by a gain-of-function mutant of the Rheb GTPase. J Biol Chem 2006; 281: 19793-19797. (Pubitemid 44065753)
16. Sato T, Umetsu A, Tamanoi F,. Characterization of the Rheb-mTOR signaling pathway in mammalian cells: constitutive active mutants of Rheb and mTOR. Methods Enzymol 2008; 438: 307-320.
17. Ries V, Henchcliffe C, Kareva T, et al. Oncoprotein Akt/PKB: trophic effects in murine models of Parkinson's disease. Proc Natl Acad Sci U S A 2006; 103: 18757-18762. (Pubitemid 44913483)
18. Silva RM, Ries V, Oo TF, et al. CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism. J Neurochem 2005; 95: 974-986. (Pubitemid 41713483)
19. Kholodilov N, Yarygina O, Oo TF, et al. Regulation of the development of mesencephalic dopaminergic systems by the selective expression of glial cell line-derived neurotrophic factor in their targets. J Neurosci 2004; 24: 3136-3146. (Pubitemid 38405761)
20. Cheng HC, Burke RE,. The Wld(S) mutation delays anterograde, but not retrograde, axonal degeneration of the dopaminergic nigro-striatal pathway in vivo. J Neurochem 2010; 113: 683-691.
21. Cheng HC, Kim SR, Oo TF, et al. AKT suppresses retrograde degeneration of dopaminergic axons by inhibition of macroautophagy. J Neurosci 2011; (in press).
22. Stettler O, Bush MS, Kasper M, et al. Monoclonal antibody 2G13, a new axonal growth cone marker. J Neurocytol 1999; 28: 1035-1044.
23. Maier IC, Baumann K, Thallmair M, et al. Constraint-induced movement therapy in the adult rat after unilateral corticospinal tract injury. J Neurosci 2008; 28: 9386-9403.
24. Steward O, Zheng B, Tessier-Lavigne M,. False resurrections: distinguishing regenerated from spared axons in the injured central nervous system. J Comp Neurol 2003; 459: 1-8. (Pubitemid 36348860)
25. Liu BP, Cafferty WB, Budel SO, et al. Extracellular regulators of axonal growth in the adult central nervous system. Philos Trans R Soc Lond B Biol Sci 2006; 361: 1593-1610. (Pubitemid 44450213)
26. Yiu G, He Z,. Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 2006; 7: 617-627. (Pubitemid 44106744)
27. Choi YJ, Di Nardo A, Kramvis I, et al. Tuberous sclerosis complex proteins control axon formation. Genes Dev 2008; 22: 2485-2495.
28. Campbell DS, Holt CE,. Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation. Neuron 2001; 32: 1013-1026. (Pubitemid 34075393)
29. Read DE, Gorman AM,. Involvement of Akt in neurite outgrowth. Cell Mol Life Sci 2009; 66: 2975-2984.
30. Park KK, Liu K, Hu Y, et al. PTEN/mTOR and axon regeneration. Exp Neurol 2010; 223: 45-50.
31. Manning BD, Cantley LC,. AKT/PKB signaling: navigating downstream. Cell 2007; 129: 1261-1274. (Pubitemid 46962095)
32. Manning BD, Cantley LC,. Rheb fills a GAP between TSC and TOR. Trends Biochem Sci 2003; 28: 573-576. (Pubitemid 38352801)
33. Huang J, Manning BD,. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 2008; 412: 179-190. (Pubitemid 351758225)
34. Cheng HC, Ulane CM, Burke RE,. Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol 2010; 67: 715-725.
35. Shaw RJ, Cantley LC,. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 2006; 441: 424-430. (Pubitemid 44050136)
36. Dowling RJ, Topisirovic I, Alain T, et al. mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science 2010; 328: 1172-1176.